Milurit (Allopurinol)

Allopurinol, the active ingredient in Milurit, is a xanthine oxidase inhibitor presented as a unknown/unknown for oral use. It treats gout, hyperuricemia and is used to prevent tumor lysis syndrome in patients at risk.

GNH USA supplies Milurit as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milurit, a xanthine oxidase inhibitor, is employed in conditions related to excess uric acid production.

Gout: reduces serum uric acid to prevent acute attacks and chronic joint damage. Hyperuricemia: maintains lower uric acid levels to avoid crystal deposition and renal complications. Prevention of tumor lysis syndrome: lowers uric acid generated during rapid cell turnover in chemotherapy patients.

Adverse reactions may occur with Milurit and are categorized by frequency.

Common Side Effects: - Rash or mild skin irritation - Nausea or vomiting - Diarrhea or abdominal discomfort - Elevated liver enzymes - Headache - Dizziness

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe hypersensitivity reactions - Agranulocytosis or bone‑marrow suppression - Hepatic failure or severe liver injury - Acute renal impairment - Severe cutaneous adverse reactions

Milurit requires careful consideration of patient-specific factors before use.

Renal function: adjust dose in patients with impaired renal clearance. Hepatic function: monitor liver enzymes in patients with liver disease. Allergy: avoid if known hypersensitivity to allopurinol or excipients. Pregnancy: use only if benefits outweigh potential risks. Drug interactions: review concomitant medications such as azathioprine. Store at below 25°C: keep in the original pack, protect from moisture.

Milurit can interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Azathioprine: may increase risk of bone‑marrow suppression. - Mercaptopurine: heightened toxicity risk. - Warfarin: possible enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may reduce uric‑acid‑lowering efficacy. - ACE inhibitors: may increase hypersensitivity potential. - NSAIDs: may raise risk of renal impairment.